The rising interest in GLP-1 agonists for diabetes has generated a discussion about delivery routes : skin-applied devices versus capsules. Usually , GLP-1 therapies were only available in oral form, but https://poppyxwes129113.dbblog.net/14242337/glp-1-transdermal-delivery-systems-vs-oral-medications-is-best-for-you